Unfavorable Outcome of Neuroblastoma in Patients With 2p Gain

Background: Amplification of the MYCN oncogene is the most unfavorable genetic factor in neuroblastoma patients. However, knowledge about the clinical impact of low-level multiplication of MYCN is still insufficient. Therefore, we aimed to investigate the disease course in patients with different co...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Oncol
Main Authors: Szewczyk, Katarzyna, Wieczorek, Aleksandra, Młynarski, Wojciech, Janczar, Szymon, Woszczyk, Mariola, Gamrot, Zuzanna, Chaber, Radosław, Wysocki, Mariusz, Pogorzała, Monika, Bik-Multanowski, Mirosław, Balwierz, Walentyna
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2019
Teme:
Oncology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6794702/
https://ncbi.nlm.nih.gov/pubmed/31649880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01018
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki